High flow nasal cannula oxygenation in COVID-19 related acute respiratory distress syndrome: a safe way to avoid endotracheal intubation?
Backgrounds: High flow nasal cannula (HFNC) is an alternative therapy for acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19). This study aimed first to describe outcomes of patients suffering from COVID-19-related ARDS treated with HFNC; secondly to evaluate safety...
Main Authors: | Agathe Delbove, Ambroise Foubert, François Mateos, Tiphaine Guy, Marie Gousseff |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/17534666211019555 |
Similar Items
-
Nasal Cannula Apneic Oxygenation Prevents Desaturation During Endotracheal Intubation: An Integrative Literature Review
by: Joshua M. Gleason, et al.
Published: (2018-02-01) -
High-flow nasal cannula failure in critically ill cancer patients with acute respiratory failure: Moving from avoiding intubation to avoiding delayed intubation.
by: Colombe Saillard, et al.
Published: (2022-01-01) -
Effectiveness of high-flow nasal cannula for tracheal intubation in the emergency department
by: Yumi Mitsuyama, et al.
Published: (2022-06-01) -
High flow nasal cannula oxygenation in postoperative esophagectomy: A safe approach?
by: Debojyoti Das, et al.
Published: (2024-04-01) -
Modified high-flow nasal cannula for children with respiratory distress
by: Sarocha Itdhiamornkulchai, et al.
Published: (2022-03-01)